These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9276249)

  • 21. High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.
    Egger AE; Hartinger CG; Ben Hamidane H; Tsybin YO; Keppler BK; Dyson PJ
    Inorg Chem; 2008 Nov; 47(22):10626-33. PubMed ID: 18947179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural parameterization of the binding enthalpy of small ligands.
    Luque I; Freire E
    Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A structural perspective on protein-protein interactions.
    Russell RB; Alber F; Aloy P; Davis FP; Korkin D; Pichaud M; Topf M; Sali A
    Curr Opin Struct Biol; 2004 Jun; 14(3):313-24. PubMed ID: 15193311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational and dynamics changes induced by bile acids binding to chicken liver bile acid binding protein.
    Eberini I; Guerini Rocco A; Ientile AR; Baptista AM; Gianazza E; Tomaselli S; Molinari H; Ragona L
    Proteins; 2008 Jun; 71(4):1889-98. PubMed ID: 18175325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of protein-glycolipid recognition at the membrane bilayer.
    Evans SV; Roger MacKenzie C
    J Mol Recognit; 1999; 12(3):155-68. PubMed ID: 10398406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of long-range interactions in a PDZ domain by NMR, kinetics, and protein engineering.
    Gianni S; Walma T; Arcovito A; Calosci N; Bellelli A; Engström A; Travaglini-Allocatelli C; Brunori M; Jemth P; Vuister GW
    Structure; 2006 Dec; 14(12):1801-9. PubMed ID: 17161370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization by NMR and molecular modeling of the binding of polyisoprenols and polyisoprenyl recognition sequence peptides: 3D structure of the complexes reveals sites of specific interactions.
    Zhou GP; Troy FA
    Glycobiology; 2003 Feb; 13(2):51-71. PubMed ID: 12626407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of input differences on the results of docking calculations.
    Feher M; Williams CI
    J Chem Inf Model; 2009 Jul; 49(7):1704-14. PubMed ID: 19530660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and dynamic roles of permanent water molecules in ligand molecular recognition by chicken liver bile acid binding protein.
    Ricchiuto P; Rocco AG; Gianazza E; Corrada D; Beringhelli T; Eberini I
    J Mol Recognit; 2008; 21(5):348-54. PubMed ID: 18654997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Van der Waals interactions dominate ligand-protein association in a protein binding site occluded from solvent water.
    Barratt E; Bingham RJ; Warner DJ; Laughton CA; Phillips SE; Homans SW
    J Am Chem Soc; 2005 Aug; 127(33):11827-34. PubMed ID: 16104761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-ray crystallography of protein-ligand interactions.
    Schlichting I
    Methods Mol Biol; 2005; 305():155-66. PubMed ID: 15939997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative stability of protein structures determined by X-ray crystallography or NMR spectroscopy: a molecular dynamics simulation study.
    Fan H; Mark AE
    Proteins; 2003 Oct; 53(1):111-20. PubMed ID: 12945054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding site detection and druggability index from first principles.
    Seco J; Luque FJ; Barril X
    J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structural basis of allosteric regulation in proteins.
    Laskowski RA; Gerick F; Thornton JM
    FEBS Lett; 2009 Jun; 583(11):1692-8. PubMed ID: 19303011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational differences in liganded and unliganded states of Galectin-3.
    Umemoto K; Leffler H; Venot A; Valafar H; Prestegard JH
    Biochemistry; 2003 Apr; 42(13):3688-95. PubMed ID: 12667058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR spectroscopy of RNA.
    Fürtig B; Richter C; Wöhnert J; Schwalbe H
    Chembiochem; 2003 Oct; 4(10):936-62. PubMed ID: 14523911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unrestrained 5 ns molecular dynamics simulation of a cisplatin-DNA 1,2-GG adduct provides a rationale for the NMR features and reveals increased conformational flexibility at the platinum binding site.
    Elizondo-Riojas MA; Kozelka J
    J Mol Biol; 2001 Dec; 314(5):1227-43. PubMed ID: 11743736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.